Form 6K Innate Pharma For: 18 February
#Innate Pharma #Form 6‑K #SEC filing #February #Corporate governance #Financial reporting
📌 Key Takeaways
- Issuer: Innate Pharma
- Form type: 6‑K (Regulatory filing)
- Filing date: 18 February
- Purpose: to disclose material corporate information to investors
- Submission: with the U.S. Securities and Exchange Commission
📖 Full Retelling
On 18 February, Innate Pharma filed a Form 6‑K with the U.S. Securities and Exchange Commission. This filing was submitted to disclose material corporate developments and other information that may be relevant to investors. The Form 6‑K, a standard regulatory instrument for U.S. public companies, is used to report updates on events, regulatory changes, financial results or other information that could impact the company’s valuation.
🏷️ Themes
Regulatory compliance, Corporate disclosure, Investor transparency
Entity Intersection Graph
No entity connections available yet for this article.